A randomized controlled trial of the embrace advanced scar therapy device to reduce incisional scar formation

Michael T. Longaker, Rod J. Rohrich, Lauren Greenberg, Heather Furnas, Robert Wald, Vivek Bansal, Hisham Seify, Anthony Tran, Jane Weston, Joshua M. Korman, Rodney Chan, David Kaufman, Vipul R. Dev, Joseph A. Mele, Michael Januszyk, Christy Cowley, Peggy McLaughlin, Bill Beasley, Geoffrey C. Gurtner

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

BACKGROUND: Scarring represents a significant biomedical burden in clinical medicine. Mechanomodulation has been linked to scarring through inflammation, but until now a systematic approach to attenuate mechanical force and reduce scarring has not been possible.

METHODS: The authors conducted a 12-month, prospective, open-label, randomized, multicenter clinical trial to evaluate abdominoplasty scar appearance following postoperative treatment with the embrace Advanced Scar Therapy device to reduce mechanical forces on healing surgical incisions. Incisions from 65 healthy adult subjects were randomized to receive embrace treatment on one half of an abdominoplasty incision and control treatment (surgeon's optimal care methods) on the other half. The primary endpoint for this study was the difference between assessments of scar appearance for the treated and control sides using the visual analogue scale scar score.

RESULTS: Final 12-month study photographs were obtained from 36 subjects who completed at least 5 weeks of dressing application. The mean visual analogue scale score for embrace-treated scars (2.90) was significantly improved compared with control-treated scars (3.29) at 12 months (difference, 0.39; 95 percent confidence interval, 0.14 to 0.66; p = 0.027). Both subjects and investigators found that embrace-treated scars demonstrated significant improvements in overall appearance at 12 months using the Patient and Observer Scar Assessment Scale evaluation (p = 0.02 and p < 0.001, respectively). No serious adverse events were reported.

CONCLUSIONS: These results demonstrate that the embrace device significantly reduces scarring following abdominoplasty surgery. To the authors' knowledge, this represents the first level I evidence for postoperative scar reduction.

CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, II.

Original languageEnglish (US)
Pages (from-to)536-546
Number of pages11
JournalPlastic and Reconstructive Surgery
Volume134
Issue number3
DOIs
StatePublished - Sep 1 2014

Fingerprint

Cicatrix
Randomized Controlled Trials
Equipment and Supplies
Abdominoplasty
Therapeutics
Visual Analog Scale
Clinical Medicine
Bandages
Multicenter Studies
Healthy Volunteers
Research Personnel
Confidence Intervals
Inflammation

ASJC Scopus subject areas

  • Surgery

Cite this

Longaker, M. T., Rohrich, R. J., Greenberg, L., Furnas, H., Wald, R., Bansal, V., ... Gurtner, G. C. (2014). A randomized controlled trial of the embrace advanced scar therapy device to reduce incisional scar formation. Plastic and Reconstructive Surgery, 134(3), 536-546. https://doi.org/10.1097/PRS.0000000000000417

A randomized controlled trial of the embrace advanced scar therapy device to reduce incisional scar formation. / Longaker, Michael T.; Rohrich, Rod J.; Greenberg, Lauren; Furnas, Heather; Wald, Robert; Bansal, Vivek; Seify, Hisham; Tran, Anthony; Weston, Jane; Korman, Joshua M.; Chan, Rodney; Kaufman, David; Dev, Vipul R.; Mele, Joseph A.; Januszyk, Michael; Cowley, Christy; McLaughlin, Peggy; Beasley, Bill; Gurtner, Geoffrey C.

In: Plastic and Reconstructive Surgery, Vol. 134, No. 3, 01.09.2014, p. 536-546.

Research output: Contribution to journalArticle

Longaker, MT, Rohrich, RJ, Greenberg, L, Furnas, H, Wald, R, Bansal, V, Seify, H, Tran, A, Weston, J, Korman, JM, Chan, R, Kaufman, D, Dev, VR, Mele, JA, Januszyk, M, Cowley, C, McLaughlin, P, Beasley, B & Gurtner, GC 2014, 'A randomized controlled trial of the embrace advanced scar therapy device to reduce incisional scar formation', Plastic and Reconstructive Surgery, vol. 134, no. 3, pp. 536-546. https://doi.org/10.1097/PRS.0000000000000417
Longaker, Michael T. ; Rohrich, Rod J. ; Greenberg, Lauren ; Furnas, Heather ; Wald, Robert ; Bansal, Vivek ; Seify, Hisham ; Tran, Anthony ; Weston, Jane ; Korman, Joshua M. ; Chan, Rodney ; Kaufman, David ; Dev, Vipul R. ; Mele, Joseph A. ; Januszyk, Michael ; Cowley, Christy ; McLaughlin, Peggy ; Beasley, Bill ; Gurtner, Geoffrey C. / A randomized controlled trial of the embrace advanced scar therapy device to reduce incisional scar formation. In: Plastic and Reconstructive Surgery. 2014 ; Vol. 134, No. 3. pp. 536-546.
@article{38e176f9a88f4722ae8c2dd4f24794a1,
title = "A randomized controlled trial of the embrace advanced scar therapy device to reduce incisional scar formation",
abstract = "BACKGROUND: Scarring represents a significant biomedical burden in clinical medicine. Mechanomodulation has been linked to scarring through inflammation, but until now a systematic approach to attenuate mechanical force and reduce scarring has not been possible.METHODS: The authors conducted a 12-month, prospective, open-label, randomized, multicenter clinical trial to evaluate abdominoplasty scar appearance following postoperative treatment with the embrace Advanced Scar Therapy device to reduce mechanical forces on healing surgical incisions. Incisions from 65 healthy adult subjects were randomized to receive embrace treatment on one half of an abdominoplasty incision and control treatment (surgeon's optimal care methods) on the other half. The primary endpoint for this study was the difference between assessments of scar appearance for the treated and control sides using the visual analogue scale scar score.RESULTS: Final 12-month study photographs were obtained from 36 subjects who completed at least 5 weeks of dressing application. The mean visual analogue scale score for embrace-treated scars (2.90) was significantly improved compared with control-treated scars (3.29) at 12 months (difference, 0.39; 95 percent confidence interval, 0.14 to 0.66; p = 0.027). Both subjects and investigators found that embrace-treated scars demonstrated significant improvements in overall appearance at 12 months using the Patient and Observer Scar Assessment Scale evaluation (p = 0.02 and p < 0.001, respectively). No serious adverse events were reported.CONCLUSIONS: These results demonstrate that the embrace device significantly reduces scarring following abdominoplasty surgery. To the authors' knowledge, this represents the first level I evidence for postoperative scar reduction.CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, II.",
author = "Longaker, {Michael T.} and Rohrich, {Rod J.} and Lauren Greenberg and Heather Furnas and Robert Wald and Vivek Bansal and Hisham Seify and Anthony Tran and Jane Weston and Korman, {Joshua M.} and Rodney Chan and David Kaufman and Dev, {Vipul R.} and Mele, {Joseph A.} and Michael Januszyk and Christy Cowley and Peggy McLaughlin and Bill Beasley and Gurtner, {Geoffrey C.}",
year = "2014",
month = "9",
day = "1",
doi = "10.1097/PRS.0000000000000417",
language = "English (US)",
volume = "134",
pages = "536--546",
journal = "Plastic and Reconstructive Surgery",
issn = "0032-1052",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - A randomized controlled trial of the embrace advanced scar therapy device to reduce incisional scar formation

AU - Longaker, Michael T.

AU - Rohrich, Rod J.

AU - Greenberg, Lauren

AU - Furnas, Heather

AU - Wald, Robert

AU - Bansal, Vivek

AU - Seify, Hisham

AU - Tran, Anthony

AU - Weston, Jane

AU - Korman, Joshua M.

AU - Chan, Rodney

AU - Kaufman, David

AU - Dev, Vipul R.

AU - Mele, Joseph A.

AU - Januszyk, Michael

AU - Cowley, Christy

AU - McLaughlin, Peggy

AU - Beasley, Bill

AU - Gurtner, Geoffrey C.

PY - 2014/9/1

Y1 - 2014/9/1

N2 - BACKGROUND: Scarring represents a significant biomedical burden in clinical medicine. Mechanomodulation has been linked to scarring through inflammation, but until now a systematic approach to attenuate mechanical force and reduce scarring has not been possible.METHODS: The authors conducted a 12-month, prospective, open-label, randomized, multicenter clinical trial to evaluate abdominoplasty scar appearance following postoperative treatment with the embrace Advanced Scar Therapy device to reduce mechanical forces on healing surgical incisions. Incisions from 65 healthy adult subjects were randomized to receive embrace treatment on one half of an abdominoplasty incision and control treatment (surgeon's optimal care methods) on the other half. The primary endpoint for this study was the difference between assessments of scar appearance for the treated and control sides using the visual analogue scale scar score.RESULTS: Final 12-month study photographs were obtained from 36 subjects who completed at least 5 weeks of dressing application. The mean visual analogue scale score for embrace-treated scars (2.90) was significantly improved compared with control-treated scars (3.29) at 12 months (difference, 0.39; 95 percent confidence interval, 0.14 to 0.66; p = 0.027). Both subjects and investigators found that embrace-treated scars demonstrated significant improvements in overall appearance at 12 months using the Patient and Observer Scar Assessment Scale evaluation (p = 0.02 and p < 0.001, respectively). No serious adverse events were reported.CONCLUSIONS: These results demonstrate that the embrace device significantly reduces scarring following abdominoplasty surgery. To the authors' knowledge, this represents the first level I evidence for postoperative scar reduction.CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, II.

AB - BACKGROUND: Scarring represents a significant biomedical burden in clinical medicine. Mechanomodulation has been linked to scarring through inflammation, but until now a systematic approach to attenuate mechanical force and reduce scarring has not been possible.METHODS: The authors conducted a 12-month, prospective, open-label, randomized, multicenter clinical trial to evaluate abdominoplasty scar appearance following postoperative treatment with the embrace Advanced Scar Therapy device to reduce mechanical forces on healing surgical incisions. Incisions from 65 healthy adult subjects were randomized to receive embrace treatment on one half of an abdominoplasty incision and control treatment (surgeon's optimal care methods) on the other half. The primary endpoint for this study was the difference between assessments of scar appearance for the treated and control sides using the visual analogue scale scar score.RESULTS: Final 12-month study photographs were obtained from 36 subjects who completed at least 5 weeks of dressing application. The mean visual analogue scale score for embrace-treated scars (2.90) was significantly improved compared with control-treated scars (3.29) at 12 months (difference, 0.39; 95 percent confidence interval, 0.14 to 0.66; p = 0.027). Both subjects and investigators found that embrace-treated scars demonstrated significant improvements in overall appearance at 12 months using the Patient and Observer Scar Assessment Scale evaluation (p = 0.02 and p < 0.001, respectively). No serious adverse events were reported.CONCLUSIONS: These results demonstrate that the embrace device significantly reduces scarring following abdominoplasty surgery. To the authors' knowledge, this represents the first level I evidence for postoperative scar reduction.CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, II.

UR - http://www.scopus.com/inward/record.url?scp=85027928857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027928857&partnerID=8YFLogxK

U2 - 10.1097/PRS.0000000000000417

DO - 10.1097/PRS.0000000000000417

M3 - Article

C2 - 24804638

AN - SCOPUS:85027928857

VL - 134

SP - 536

EP - 546

JO - Plastic and Reconstructive Surgery

JF - Plastic and Reconstructive Surgery

SN - 0032-1052

IS - 3

ER -